Search Press releases Keywords From To 16 Oct 2021 Update on U.S. FDA Review of Biologics License Application (BLA) for bimekizumab Read More 8 Oct 2021 Disposals of own shares Read More 29 Sep 2021 New BIMZELX[®]▼ (bimekizumab) two-year data in moderate to severe plaque psoriasis presented at the 30th European Academy of Dermatology and Venereology (EADV) Congress Read More 24 Sep 2021 Disposals of own shares Read More 10 Sep 2021 Disposals of own shares Read More 6 Sep 2021 BIMZELX[®]▼ (bimekizumab) Receives First Positive Health Technology Assessment Worldwide Read More Pagination First page Previous page Previous … Page 48 Page 49 Page 50 Page 51 Current page 52 Page 53 Page 54 Page 55 Page 56 … Page 52 of 62 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe